Ikerian
Switzerland corporation · 2 known investors
Ikerian applies data and AI to identify biomarkers linked to chronic and systemic disorders, aggregate clinical insights, and support treatment decisions. The company serves healthcare stakeholders and drug developers by curating information and optimizing clinical workflows and operations.
Founders & leadership
SA
Stefanos ApostolopoulosExecutive Officer, Director
SD
Sandro De ZanetExecutive Officer, Director
CC
Carlos Ciller RuizExecutive Officer, Director
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$700KraisedDec 2025 · 5 investors · OtherRule 506(b)
▶$700KraisedDec 2025 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Carlos Ciller RuizExecutive Officer, Director
- Stefanos ApostolopoulosExecutive Officer, Director
- Sandro De ZanetExecutive Officer, Director
- Offering amount
- $700K
- Amount sold
- $700K
- First sale
- Sep 2024
- Incorporated
- Corporation, Switzerland
- Federal exemptions
- 06b
▶$7.9MraisedMar 2025 · 5 investors · OtherRule 506(b)
▶$7.9MraisedMar 2025 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Stefanos ApostolopoulosExecutive Officer, Director
- Sandro De ZanetExecutive Officer, Director
- Carlos Ciller RuizExecutive Officer, Director
- Offering amount
- $7.9M
- Amount sold
- $7.9M
- First sale
- May 2019
- Incorporated
- Corporation, Switzerland
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.